Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00468286
Status:
COMPLETED
Last Update Posted:
2011-03-23
First Post:
2007-04-13
Brief Title:
Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy
Sponsor:
Ferring Pharmaceuticals
Organization:
Ferring Pharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Prostate Cancer |
Keywords:
| Name | View |
|---|---|
| Prostate Cancer | View |